Method for Generating T Cells Progenitors
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,426,430 | Method for Generating T Cells Progenitors Assistance Publique - Hopitaux de Paris, Fondation Imagine - Institut des Maladies Génétiques, Universite Paris Descartes and Institut National de la Sante et de la Recherche Medicale (Inserm) In force · High confidence | Assistance Publique - Hopitaux de Paris, Fondation Imagine - Institut des Maladies Génétiques, Universite Paris Descartes and Institut National de la Sante et de la Recherche Medicale (Inserm) | In force | High confidence | ||
| US 11,638,723 | Method for Generating T Cells Progenitors In force · High confidence | Universite de Paris | In force | High confidence | ||
| US 11,642,376 | Method for Generating T Cell Progenitors In force · High confidence | Universite de Paris | In force | High confidence | ||
| Application 16/485,488 | Method for Generating T Cells Progenitors Abandoned Abandoned Sep 25, 2024 | Université Paris Cité | Abandoned | Abandoned Sep 25, 2024 | ||
| Application 18/296,623 | Method for Generating T Cells Progenitors Pending Not granted | Assistance Publique - Hopitaux de Paris | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Fondation Imagine.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.